Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: A randomized controlled trial

Obstetrics and Gynecology

Volumn 125, Issue 2, 2015, Pages 490-

  Koren, Gideon ^a   Maltepe, Caroline ^a   Madjunkova, Svetlana ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYLAMINE; ONDANSETRON; PYRIDOXINE;

FEMALE; HUMAN; LETTER; MORNING SICKNESS; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DOXYLAMINE; FEMALE; HUMANS; MORNING SICKNESS; ONDANSETRON; PREGNANCY; PYRIDOXINE;

EID: 84922391154     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000649     Document Type: Letter

References (5)

1. Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD.Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. Obstet Gynecol 2014; 124: 735-42
2. Madjunkova S, Maltepe C, Koren G. The delayed-release combination of doxylamine and pyridoxine (Diclegis-/Diclectin-) for the treatment of nausea and vomiting of pregnancy. Paediatr Drugs 2014; 16: 199-211
3. Ebrahimi N, Maltepe C, Bournissen FG, Koren G. Nausea and vomiting of pregnancy: using the 24-hour pregnancyunique quantification of emesis (PUQE-24) scale. J Obstet Gynaecol Can 2009; 31: 803-7
4. Koren G. Treating morning sickness in the United States-changes in prescribing are needed. Am J Obstet Gynecol 2014; 211: 602-6
5. Danielsson B, Wikner BN, Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol 2014; 50: 134-7